Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
ACHIEVE LIFE SCIENCES, INC.Listing on record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
ACHIEVE LIFE SCIENCES, INC.Listing on record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Ventyx Biosciences, Inc.Listing unverified | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Ventyx Biosciences, Inc.Listing unverified | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Ventyx Biosciences, Inc.Listing unverified | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Ventyx Biosciences, Inc.Listing unverified | Buy | $5M | conv 42Cluster | SEC | |
Ventyx Biosciences, Inc.Listing unverified | Other | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Ventyx Biosciences, Inc.Listing unverified | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Elevation Oncology, Inc.Listing unverified | Buy | $10M | conv 62ClusterFirst in 12mo | SEC | |
Elevation Oncology, Inc.Listing unverified | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Elevation Oncology, Inc.Listing unverified | Other | n/a (No price was disclosed in the filing) | SEC | ||
Yarrow Bioscience, Inc.Security delisted | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Yarrow Bioscience, Inc.Security delisted | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Akero Therapeutics, Inc.Listing unverified | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Akero Therapeutics, Inc.Listing unverified | Buy | $4M | conv 69ClusterFirst in 12mo | SEC | |
Akero Therapeutics, Inc.Listing unverified | Other | n/a (No price was disclosed in the filing) | SEC | ||
Akero Therapeutics, Inc.Listing unverified | Other | n/a (No price was disclosed in the filing) | SEC | ||
Akero Therapeutics, Inc.Listing unverified | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |